[1. European Cardiovascular Disease Statistics 2017. Avaible at: http://www.ehnheart.org/cvd-statistics.html]Search in Google Scholar
[2. Konstam MA, Kramer DG, Patel AR, et al. Left ventricular remodeling in heart failure current concepts in clinical significance and assessment. J Am Coll Cardiol Img. 2011;4:98-108.10.1016/j.jcmg.2010.10.00821232712]Search in Google Scholar
[3. Abbate A, Biondi-Zoccai GG, Appleton DL, et al. Survival and cardiac remodeling benefits in patients undergoing late percutaneous coronary intervention of the infarct-related artery: evidence from a meta-analysis of randomized controlled clinical trials. J Am Coll Cardiol. 2008;21:956-964.10.1016/j.jacc.2007.11.06218308165]Search in Google Scholar
[4. David G, David AB. MRI determination of myocardial viability. Appl Radiol. 2006;35.]Search in Google Scholar
[5. Frangioni JV, Hajjar RJ. In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation. 2004;110:3378-3383.10.1161/01.CIR.0000149840.46523.FC15557385]Search in Google Scholar
[6. Chen IY, Wu JC. Cardiovascular molecular imaging: focus on clinical translation. Circulation. 2011;123:425-443.10.1161/CIRCULATIONAHA.109.916338307367821282520]Search in Google Scholar
[7. Comella K, Griffeth J. Stem Cell Research in the Cardiac Field: Where Are We Now? World Stem Cell Report. 2009.]Search in Google Scholar
[8. Krishna KA, Krishna KS, Berrocal R, Rao KS, Sambasiva Rao KRS. Myocardial infarction and stem cells. Myocardial infarction and stem cells. J Pharm Bioallied Sci. 2011;3:182-188.10.4103/0975-7406.80761310391121687345]Search in Google Scholar
[9. Perin EC, López J. Methods of stem cell delivery in cardiac diseases. Nat Clin Pract Cardiovasc Med. 2006:Suppl1:110-113.10.1038/ncpcardio044716501616]Search in Google Scholar
[10. Bodo-Eckehard S, Gustav S. 10 Years of Intracoronary and Intramyocardial Bone Marrow Stem Cell Therapy of the Heart. J Am Coll Cardiol. 2011;58:1095-1104.10.1016/j.jacc.2011.06.01621884944]Search in Google Scholar
[11. Whitney F, Rony A. Therapeutic use of stem cells for cardiovascular disease. Clin Transl Med. 2016;5:34.]Search in Google Scholar
[12. Donndorf P, Strauer BE. Stem cell therapy for the treatment of acute myocardial infarction and chronic ischemic heart disease. Curr Pharm Biotechnol. 2013;14:12-19.]Search in Google Scholar
[13. Lau JF, Anderson SA, Adler E, Frank JA. Imaging approaches for the study of cell-based cardiac therapies. Nat Rev Cardiol. 2009;7:97-105.10.1038/nrcardio.2009.227284730820027188]Search in Google Scholar
[14. Mahrholdt H, Wagner A, Holly TA, et al. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation. 2002;106: 2322-2327.10.1161/01.CIR.0000036368.63317.1C12403661]Search in Google Scholar
[15. Al Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation. 2000;101:1379-1383.10.1161/01.CIR.101.12.137910736280]Search in Google Scholar
[16. Baer FM, Theissen P, Schneider CA, et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol. 1998;31:1040-1048.10.1016/S0735-1097(98)00032-1]Search in Google Scholar
[17. Hassan AA, Anja Z. Delayed Enhancement and T2-Weighted Cardiovascular Magnetic Resonance Imaging Differentiate Acute From Chronic Myocardial Infarction. Circulation. 2003;107:2290-2293.]Search in Google Scholar
[18. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374-379.10.1016/S0140-6736(03)12389-6]Search in Google Scholar
[19. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J. 2007;28:2525-2538.10.1093/eurheartj/ehm355]Search in Google Scholar
[20. Dash R, Kim PJ, Matsuura Y, et al. Manganese-enhanced MRI enables in vivo confirmation of peri-infarct restoration following stem cell therapy in porcine ischemia-reperfusion model. J Am Heart Assoc. 2015;4:e002044.10.1161/JAHA.115.002044]Search in Google Scholar
[21. Choi KM, Kim RJ, Gubernikoff G, et al. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation. 2001;104:1101-1107.10.1161/hc3501.096798]Search in Google Scholar
[22. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JAC. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation. 2002;106:1083-1089.10.1161/01.CIR.0000027818.15792.1E]Search in Google Scholar
[23. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation.1999;100:1992-2002.10.1161/01.CIR.100.19.1992]Search in Google Scholar
[24. van Assche LMR, Kim HW, Kim RJ. Cardiac Mr For The Assessment Of Myocardial Viability. Methodist Debakey Cardiovascular Journal. 2013;9:163-168.10.14797/mdcj-9-3-163]Search in Google Scholar
[25. Romero J, Xue X, Gonzalez W, et al. CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials. JACC Cardiovasc Imaging. 2012;5:494-508.10.1016/j.jcmg.2012.02.009]Search in Google Scholar
[26. Cwajg JM, Cwajg E, Nagueh SF, et al. End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: relation to rest-redistribution T1-201 tomography and dobutamine stress echocardiography. J Am Coll Cardiol. 2000;35:1152-1161.10.1016/S0735-1097(00)00525-8]Search in Google Scholar
[27. Shah DJ, Kim HW, Elliott M, et al. Contrast MRI predicts reverse remodeling and contractile improvement in akinetic thinned myocardium. Circulation. 2003;108:697.]Search in Google Scholar
[28. Wu YW, Tadamura E, Yamamuro M, et al. Comparison of contrast-enhanced MRI with (18) F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease. J Nucl Med. 2007;48:1096-1103.10.2967/jnumed.106.03859617607039]Search in Google Scholar
[29. Grover S, Srinivasan G, Selvanayagam JB. Myocardial viability imaging: does it still have a role in patient selection prior to coronary revascularisation? Heart Lung Circ. 2012;21:468-479.]Search in Google Scholar
[30. Xi L, Rui X, Zhang B, Gao F. MRI tracking stem cells transplantation for coronary heart disease. Pak J Med Sci. 2014;30:899-903.]Search in Google Scholar
[31. Sterenczak KA, Meier M, Glage S, et al. Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer. BMC Cancer. 2012;12:284.10.1186/1471-2407-12-284352011322784304]Search in Google Scholar
[32. Guenoun J, Koning GA, Doeswijk G, et al. Cationic Gd-DTPA liposomes for highly efficient labeling of mesenchymal stem cells and cell tracking with MRI. Cell Transplant. 2012;21:191-205.10.3727/096368911X59311821929868]Search in Google Scholar
[33. Mamani JB, Pavon LF, Miyaki LA, et al. Intracellular labeling and quantification process by magnetic resonance imaging using iron oxide magnetic nanoparticles in rat C6 glioma cell line. Einstein. 2012;10:216-221.10.1590/S1679-4508201200020001623052458]Search in Google Scholar
[34. Vuong QL, Van Doorslaer S, Bridot JL, et al. Paramagnetic nanoparticles as potential MRI contrast agents: characterization, NMR relaxation, simulations and theory. MAGMA. 2012; 25:467-478.10.1007/s10334-012-0326-722790646]Search in Google Scholar
[35. Bowen CV, Zhang X, Saab G, Gareau PJ, Rutt BK. Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells. Magn Reson Med. 2002;48:52-61.10.1002/mrm.1019212111931]Search in Google Scholar
[36. Moriel V. Cardiac Cell Tracking with MRI Reporter Genes: Welcoming a New Field. Curr Cardiovasc Imaging Rep. 2014;7:9250.10.1007/s12410-013-9250-0390518424489982]Search in Google Scholar
[37. Vandsburger MH, Radoul M, et al. MRI reporter genes: applications for imaging of cell survival, proliferation, migration and differentiation. NMR Biomed. 2013;26:872-84.10.1002/nbm.2869371340723225197]Search in Google Scholar
[38. Lee SW, Lee SH, et al. Magnetic resonance reporter gene imaging. Theranostics.2012;2:403-12.10.7150/thno.3634333773222539936]Search in Google Scholar
[39. Naumova AV, Reinecke H, et al. Ferritin overexpression for noninvasive magnetic resonance imaging-based tracking of stem cells transplanted into the heart. Mol Imaging. 2010 Aug;9:201-210.10.2310/7290.2010.00020]Search in Google Scholar
[40. Naumova AV, Yarnykh VL, Cohen B, Neeman M. Quantification of MRI signal of transgenic grafts overexpressing ferritin in murine myocardial infarcts. NMR Biomedicine. 2012;25:1187-1195.10.1002/nbm.2788338913122362654]Search in Google Scholar
[41. Moriel Vandsburger. Cardiac Cell Tracking with MRI Reporter Genes: Welcoming a New Field. Curr Cardiovasc Imaging Rep. 2014;7:9250.10.1007/s12410-013-9250-0390518424489982]Search in Google Scholar
[42. Patricia KN, Feng L, Wang Y, Wu JC. Imaging: Guiding the Clinical Translation of Cardiac Stem Cell Therapy. Circ Res. 2011;109:962-979.10.1161/CIRCRESAHA.111.242909320696721960727]Search in Google Scholar
[43. David E. Sosnovik. Seeing What We Build—The Need for New Imaging Techniques in Myocardial Regeneration. J Am Heart Assoc. 2015;4:e002306.10.1161/JAHA.115.002306460809826215973]Search in Google Scholar
[44. Cao F, Lin S, Xie X, et al. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation. 2006;113:1005-1014.10.1161/CIRCULATIONAHA.105.588954470138416476845]Search in Google Scholar
[45. Terrovitis JV, Smith RR, Marbán E. Assessment and Optimization of Cell Engraftment after Transplantation into the Heart. Circ Res. 2010;106:479-494.10.1161/CIRCRESAHA.109.208991282672220167944]Search in Google Scholar
[46. Amsalem Y, Mardor Y, Feinberg MS, et al. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation. 2007;116:38-45.10.1161/CIRCULATIONAHA.106.68023117846324]Search in Google Scholar
[47. Terrovitis J, Stuber M, et al. Iron-labeled stem cells seen by magnetic resonance imaging: dead or alive? Circulation. 2006;114:264.]Search in Google Scholar
[48. Partlow KC, Chen J, Brant J, Wickline SA. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J. 2007;21:1647-1654.10.1096/fj.06-6505com17284484]Search in Google Scholar
[49. Berry MF, Engler AJ, Woo YJ, et al. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol. 2006;290:2196-2203.10.1152/ajpheart.01017.200516473959]Search in Google Scholar
[50. Nesteruk J, Voronina N, Kundt G, et al. Stem cell registry programme for patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting: what benefits does it derive? ESC Heart Fail. 2017;4:105-111.]Search in Google Scholar
[51. Traverse JH, Henry TD, Pepine CJ, Willerson JT, Ellis SG. One-Year Follow-up of Intracoronary Stem Cell Delivery on Left-Ventricular Function Following ST-Elevation Myocardial Infarction. JAMA. 2014;311:301-302.10.1001/jama.2013.282674426933324247415]Search in Google Scholar
[52. Malliaras K, Makkar RR, Smith RR, et al. Intracoronary Cardiosphere-Derived Cells After Myocardial Infarction: Evidence of Therapeutic Regeneration in the Final 1-Year Results of the CADUCEUS Trial. J Am Coll Cardiol. 2014;63(2):110-122.10.1016/j.jacc.2013.08.724394706324036024]Search in Google Scholar
[53. Lipinski MJ, Biondi-Zoccai GG, Abbate A, Vetrovec GW. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol. 2007;50:1761-1767.10.1016/j.jacc.2007.07.04117964040]Search in Google Scholar
[54. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J. 2008;29:1807-1818.10.1093/eurheartj/ehn22018523058]Search in Google Scholar
[55. Delewi R, Hirsch A, Tijssen JG, et al. Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis. Eur Heart J. 2014;35:989-998.10.1093/eurheartj/eht372427110024026778]Search in Google Scholar
[56. Jeevanantham V, Butler M, Saad A, et al. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation. 2012;126:551-568.10.1161/CIRCULATIONAHA.111.086074428264922730444]Search in Google Scholar